Navigation Links
Biopure Announces 2008 Third Quarter Financial Results
Date:8/21/2008

Total operating expenses 2,995 4,066 10,912 12,861

Loss from operations (4,649) (6,605) (15,692) (20,124)

Other income, net 53 157 438 528

Net loss $(4,596) $(6,448) $(15,254) $(19,596)

Basic and diluted net

loss per common share $(0.13) $(0.41) $(0.44) $(1.33)

Weighted-average common

shares outstanding 35,602 15,591 34,829 14,693

The net loss per common share for the three and nine month periods ended July 31, 2007 has been adjusted to reflect the one-for-five reverse split that took effect on October 2, 2007.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

(Unaudited)

July 31, 2008 October 31, 2007

Assets

Total current assets $5,918 $5,253

Net property and equipment 7,199 8,398

Other assets 610 599

Total assets $13,727 $14,250

Liabilities and stockholders' equity

Total current liabilities $2,176 $3,368

Deferred revenue, net of current portion 1,177 1,177

Other long term liabilities - 41

Total liabilities 3,353 4,586

Total stockholders' equity 10,374 9,664

Total liabilities and stockholders' equity $13,727 $14,250


'/>"/>
SOURCE Biopure Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Biopure Announces Private Equity Financing
2. Biopure Granted Additional 180 Day Compliance Period by NASDAQ
3. Biopure Announces MHRA Meeting Update
4. Biopure Announces 2008 Second Quarter Financial Results
5. Biopure Appoints Dechra Exclusive U.S. Distributor of Oxyglobin
6. Biopure Announces Date to Meet with UKs Medicines and Healthcare Products Agency
7. Biopure Operations Compliant With U.K. Manufacturing Guidelines
8. Biopure Appoints New Independent Auditor
9. Biopure Completes U.K. Regulatory Agency Inspection
10. Biopure Announces 2008 First Quarter Financial Results
11. Biopure Launches Updated Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... 16, 2015  In recognition of World Hemophilia Day, ... groups to illuminate more than 15 prominent landmarks red throughout ... Boston,s Zakim Bridge and Prudential Tower, ... Mercedes-Benz Superdome and Denver,s ... of April 17, and coincide with hemophilia community events in ...
(Date:4/16/2015)... MOSCOW , April 16, 2015 /PRNewswire/ ... (ChemRar), the Russian pharmaceutical investment and R&D ... announced collaboration for research, development and commercialization ... with the intention to stimulate ... industry.      (Logo: http://photos.prnewswire.com/prnh/20150416/739742-a) ,     ...
(Date:4/16/2015)... Avelas Biosciences, an in vivo ... today that it has initiated a Phase 1b study ... with primary, non-recurrent breast cancer undergoing surgery. In commencing ... of Steven Chen , M.D., as vice president ... escalation study will enroll up to 39 women with ...
(Date:4/16/2015)... Fairleigh Dickinson University ( FDU ... become the Executive Director of the Rothman Institute ... kick-off of the Initiative for Patient Centered Innovation ... under the Rothman Institute of Innovation and Entrepreneurship ... collaboration with FDU’s School of Pharmacy’s Center for ...
Breaking Biology Technology:Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 3Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 4Lancet and ChemRar High Tech Center Have Announced a Partnership in the Development and Production of Novel Drugs in Russia 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 2Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 3
... Lightwave Logic, Inc. (OTC Bulletin Board: LWLG - News; ... development of electro-optic polymer materials for applications in high ... addition of Anthony J. Cocuzza, PhD to our technology ... chemistry and brings a highly developed set of synthetic ...
... of the world,s most widely used drugs, is also one ... it are at risk of serious problems when given the ... illustrations of "personalized medicine" based on genetic information, an international ... the best dose of the blood-thinning drug for each patient. ...
... developed by researchers at the University of Illinois overcomes ... structure of a single nanocrystal with a resolution of ... a centimeter)., Optical and electronic properties of small assemblages ... structure not just what,s on the surface, but ...
Cached Biology Technology:Lightwave Logic, Inc. Announces the Addition of Anthony J. Cocuzza, PhD to its Technology Team 2Genetic information personalizes warfarin prescribing 2Genetic information personalizes warfarin prescribing 3New imaging technique reveals the atomic structure of nanocrystals 2
(Date:4/2/2015)... 2, 2015 In the ... far outperforms the strongest competitors, showing outstanding performance ... the system is capable of a throughput of ... up to be ten times faster than most ... performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
(Date:4/2/2015)... 2015 Fingerprint Cards (FPC) has ... from the distributor World Peace Industrial Group (WPI), part ... although the major part of the shipments will take ... by smartphone manufacturers in China . ... the communicated revenue guidance of + 1 000 MSEK for ...
(Date:3/31/2015)... YORK , March 31, 2015  Elephant Talk ... "Company"), a global provider of Software Defined Network Architecture ... today announced total revenue of approximately $20.4 million for ... a restated $19.5 million for the year ended December ... calendar 2014, the Company had completed its multi-year transition ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6
... American Dental Association Foundation (ADAF) and the National ... a new method for layering two kinds of ... may lead to improved reconstruction or repair of ... of powdered calcium and a phosphate compound that ...
... National Institute of Standards and Technology (NIST) has issued ... biloba, one of the most popular dietary supplements in ... billion. The NIST reference materials are designed ... for flavonoids and terpene lactones (plant constituents that may ...
... storage molecule PKMzeta maintains long-term memories in ... order for the memory to endure, according to a ... Israel and SUNY Downstate Medical Center in Brooklyn, New ... edition of Science magazine ( www.sciencemag.org ). The title ...
Cached Biology News:Layered approach may yield stronger, more successful bone implants 2Ginkgo SRMs: Tools for product analysis/quality 2
... U. Desselberger (1995) • This ... brings together classical and molecular techniques ... virus infections and analysis of virus-specific ... protocols are presented covering immunoassays, blotting ...
Bovine Serum...
Mus musculus junctophilin 2 (Jph2) Antigen: Recombinant Protein...
2.0 GHz Compaq Computer with 512 MB RAM, 32 MB AGP Graphics Card, 40 GB Hard Drive, 1 Serial Port & Open PCI Slot, Windows 2000 OS, MS Office, CD Read/Writer and 18 Flat Panel Monitor...
Biology Products: